Cathelicidin LL-37: A central factor in the pathogenesis of inflammatory dermatoses? [Cathelicidin LL-37: Ein zentraler faktor in der pathogenese entzündlicher dermatosen?]

被引:0
|
作者
Schauber J. [1 ,2 ]
Ruzicka T. [1 ]
Rupec R.A. [1 ]
机构
[1] Klinik und Poliklinik für Dermatologie und Allergologie, Ludwig-Maximilians-Universität München, 80337 München
来源
Der Hautarzt | 2008年 / 59卷 / 1期
关键词
Antimicrobial peptides; Atopic eczema; Cathelicidin; Psoriasis; Rosacea;
D O I
10.1007/s00105-007-1457-z
中图分类号
学科分类号
摘要
Keratinocytes produce and secrete antimicrobial peptides which function as endogenous antibiotics and as signaling molecules within the cutaneous innate immune system. Recent studies demonstrate that the antimicrobial peptide cathelicidin LL-37 plays an important role in the pathogenesis of atopic eczema, rosacea and psoriasis. Whereas skin in atopic eczema shows decreased cathelicidin expression which leads to increased susceptibility to superinfection in those patients, overabundant expression of cathelicidin peptide fragments causes inflammation in rosacea. Finally, in psoriasis cathelicidin peptide binds to self DNA which triggers an autoimmune response. These studies demonstrate the role of cathelicidin as a central factor in the pathogenesis of cutaneous inflammation. Therapies targeting cathelicidin expression and function could lead to new treatments for these diseases. © 2007 Springer Medizin Verlag.
引用
收藏
页码:72 / 74
页数:2
相关论文
共 50 条
  • [1] Cathelicidin LL-37 - A central factor in the pathogenesis of inflammatory dermatoses?
    Schauber, J.
    Ruzicka, T.
    Rupec, R. A.
    HAUTARZT, 2008, 59 (01): : 72 - 74
  • [2] The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease
    Sun, Lihua
    Wang, Wensheng
    Xiao, Weidong
    Yang, Hua
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (08) : 1986 - 1991
  • [3] Cathelicidin LL-37: A Multitask Antimicrobial Peptide
    Bucki, Robert
    Leszczynska, Katarzyna
    Namiot, Andrzej
    Sokolowski, Wojciech
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2010, 58 (01) : 15 - 25
  • [4] Cathelicidin LL-37: A Multitask Antimicrobial Peptide
    Robert Bucki
    Katarzyna Leszczyńska
    Andrzej Namiot
    Wojciech Sokołowski
    Archivum Immunologiae et Therapiae Experimentalis, 2010, 58 : 15 - 25
  • [5] The Role of Cathelicidin LL-37 in Cancer Development
    Ewelina Piktel
    Katarzyna Niemirowicz
    Urszula Wnorowska
    Marzena Wątek
    Tomasz Wollny
    Katarzyna Głuszek
    Stanisław Góźdź
    Ilya Levental
    Robert Bucki
    Archivum Immunologiae et Therapiae Experimentalis, 2016, 64 : 33 - 46
  • [6] Unique features of human cathelicidin LL-37
    Bandurska, Katarzyna
    Berdowska, Agnieszka
    Barczynska-Felusiak, Renata
    Krupa, Piotr
    BIOFACTORS, 2015, 41 (05) : 289 - 300
  • [7] The Role of Cathelicidin LL-37 in Cancer Development
    Piktel, Ewelina
    Niemirowicz, Katarzyna
    Wnorowska, Urszula
    Watek, Marzena
    Wollny, Tomasz
    Gluszek, Katarzyna
    Gozdz, Stanislaw
    Levental, Ilya
    Bucki, Robert
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2016, 64 (01) : 33 - 46
  • [8] Expression of cathelicidin (LL-37) in thermal injury
    不详
    WOUND REPAIR AND REGENERATION, 2005, 13 (02) : A38 - A38
  • [9] Cathelicidin LL-37: a defense molecule with a potential role in psoriasis pathogenesis
    Dombrowski, Yvonne
    Schauber, Juergen
    EXPERIMENTAL DERMATOLOGY, 2012, 21 (05) : 327 - 330
  • [10] Low serum levels of cathelicidin LL-37 in leprosy
    Matzner, Michael
    Al Samie, Abdul Rahim
    Winkler, Heide-Maria
    Nemeth, Johannes
    Grasnek, Andreas
    Indra, Alexander
    Bieglmayer, Christian
    Winkler, Stefan
    ACTA TROPICA, 2011, 117 (01) : 56 - 59